researchers have identified and validated sac3d1 as a prognostic biomarker that may promote the development of osteosarcoma. this finding suggests a potential link between sac3d1 and the progression of the disease. sac3d1 is reportedly associated with osteosarcoma, although the nature and extent of this association are not further detailed.